메뉴 건너뛰기




Volumn 41, Issue 6, 2013, Pages 1456-1458

Multidrug-resistant tuberculosis in UK children: Presentation, management and outcome

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

EID: 84878808141     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00179712     Document Type: Letter
Times cited : (9)

References (10)
  • 1
    • 77952542701 scopus 로고    scopus 로고
    • Multi-drug resistant and extensively drug-resistant tuberculosis: A threat to global control of tuberculosis
    • Gandhi NR, Nunn P, Dheda K, et al. Multi-drug resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-1843.
    • (2010) Lancet , vol.375 , pp. 1830-1843
    • Gandhi, N.R.1    Nunn, P.2    Dheda, K.3
  • 2
    • 84864745953 scopus 로고    scopus 로고
    • Childhood tuberculosis: Progress requires an advocacy strategy now
    • Sandgren A, Cuevas LE, Dara, et al. Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J 2012; 40: 294-297.
    • (2012) Eur Respir J , vol.40 , pp. 294-297
    • Sandgren, A.1    Cuevas, L.E.2    Dara3
  • 3
    • 33745837528 scopus 로고    scopus 로고
    • The bacteriological yield in children with intrathoracic tuberculosis
    • Marais BJ, Hesseling AC, Gie RP, et al. The bacteriological yield in children with intrathoracic tuberculosis. Clin Infect Dis 2006; 42: e69-e71.
    • (2006) Clin Infect Dis , vol.42
    • Marais, B.J.1    Hesseling, A.C.2    Gie, R.P.3
  • 4
    • 84555204786 scopus 로고    scopus 로고
    • Culture-confirmed multi-drug resistant tuberculosis in children: Clinical features, treatment and outcome
    • Seddon JA, Hesseling AC, Willemse M, et al. Culture-confirmed multi-drug resistant tuberculosis in children: clinical features, treatment and outcome. Clin Infect Dis 2012; 54: 157-166.
    • (2012) Clin Infect Dis , vol.54 , pp. 157-166
    • Seddon, J.A.1    Hesseling, A.C.2    Willemse, M.3
  • 5
    • 84861341121 scopus 로고    scopus 로고
    • Treatment outcomes for children with multi-drug resistant tuberculosis: A systematic review and meta-analysis
    • Ettehad D, Schaaf HS, Seddon JA, et al. Treatment outcomes for children with multi-drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 449-456.
    • (2012) Lancet Infect Dis , vol.12 , pp. 449-456
    • Ettehad, D.1    Schaaf, H.S.2    Seddon, J.A.3
  • 6
    • 80053067126 scopus 로고    scopus 로고
    • WHO Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 Update
    • Falzon D, Jaramillo E, Schünemann HJ, et al. WHO Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
    • (2011) Eur Respir J , vol.38 , pp. 516-528
    • Falzon, D.1    Jaramillo, E.2    Schünemann, H.J.3
  • 9
    • 84863933651 scopus 로고    scopus 로고
    • London, Available from: Date last accessed: December 19, 2012. Date last updated: December 16, 2011
    • Pedrazzoli D, Kruijshaar M, Anderson L, et al. Tuberculosis in the UK: 2011 Report. London, Health Protection Agency, 2011. Available from: www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb-/1317131784267 Date last accessed: December 19, 2012. Date last updated: December 16, 2011.
    • (2011) Tuberculosis in the UK: 2011 Report
    • Pedrazzoli, D.1    Kruijshaar, M.2    Anderson, L.3
  • 10
    • 79957998404 scopus 로고    scopus 로고
    • Drug-resistant Tuberculosis: Pediatric Guidelines
    • Al-Dabbagh M, Lapphra K, McGloin R, et al. Drug-resistant Tuberculosis: Pediatric Guidelines. Pediatr Infect Dis J 2011; 30: 501-505.
    • (2011) Pediatr Infect Dis J , vol.30 , pp. 501-505
    • Al-Dabbagh, M.1    Lapphra, K.2    McGloin, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.